Reaction Biology is a renowned brand that is dedicated to helping patients with effective treatments. Since its founding in 2001, Reaction Biology has been committed to providing personalized and collaborative research experiences to its clients. The primary focus of the brand is to aid organizations in discovering drug candidates for the treatment of various diseases, including cancer.

With a team of PhD scientists and state-of-the-art research facilities, Reaction Biology offers a wide range of services, including target-specific assays, kinase assays, epigenetic assays, GPCR assays, and more. The brand also specializes in preclinical drug discovery, offering support from target validation to hit identification and lead optimization. Reaction Biology has gained recognition worldwide, serving over 100 clients annually and generating substantial publication citations.

As a leading Contract Research Organization (CRO) for drug discovery, Reaction Biology continues to deliver high-quality data, support, and innovative solutions to meet the research needs of its clients